Cargando…
Bone marrow transplantation for thalassemia
Early trials of allogeneic bone marrow transplantation (BMT) for homozygous beta-thalassemia and the analyses of results of transplantation in patients less then 16 years old have allowed us to identify three classes of risk using the criteria of degree of hepatomegaly, the degree of portal fibrosis...
Autores principales: | Lucarelli, G., Angelucci, E., Giardini, C., Baronciani, D., Galimberti, M., Polchi, P., Erer, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102227/ https://www.ncbi.nlm.nih.gov/pubmed/8262588 http://dx.doi.org/10.1007/BF02751428 |
Ejemplares similares
-
Bone marrow transplantation from alternative donors for thalassemia: HLA-phenotypically identical relative and HLA-nonidentical sibling or parent transplants
por: Gaziev, D, et al.
Publicado: (2000) -
The Spectrum of Beta-Thalassemia Mutations in Syrian Refugees and Turkish Citizens
por: Gunes, Ahmet Kursad, et al.
Publicado: (2021) -
Nutritional Status in a Sample of Patients With β-Thalassemia Major
por: Lidoriki, Irene, et al.
Publicado: (2022) -
Type 5 Familial Hemophagocytic Lymphohistiocytosis in a Seven-year-old Girl Post Second Bone Marrow Transplantation with Failure to Thrive: STXBP2 Novel Mutation
por: Baothman, Abdullah, et al.
Publicado: (2019) -
Prevalence of Transfusion Transmitted Infections and the Quality of Life in β-thalassemia Major Patients
por: Al-Moshary, May, et al.
Publicado: (2019)